Search results
Added:
1 year ago
How should obesity be redefined to establish objective criteria for improved disease diagnosis?In this short interview, Dr Robert Eckel (University of Colorado Anschutz Medical Campus, Aurora, US) discusses the recently published article, "Definition and diagnostic criteria of clinical obesity" based on the Lancet Diabetes and Endocrinology Commission's new consensus redefining obesity. The…
View more
Added:
10 months ago
ERA 2025 - Dr Ruben Nogueiras (University of Santiago de Compostela, Santiago, ES) joins us to discuss upcoming treatments that will soon be approved for the treatment of obesity, including dual agonists that will also target type two diabetes. As well as exploring the evolution of our understanding and classification of obesity, Dr Nogueiras shares his view of obesity a multifactorial disease…
View more
Added:
1 year ago
In the first session of Advancements in Obesity Management (AOM) 2024, the panel introduce a patient living with obesity, including current diagnosis and cardiovascular complications of the disease. Furthermore, the emerging data leading to a revolution in the treatment of obesity is discussed.
View more
Added:
6 months ago
HFSA 25 - Sex-specific outcomes of tirzepatide in obesity-related HFpEF showed that at baseline, women with HFpEF had more severe heart failure symptoms.Dr Barry Borlaug (Mayo Clinic, US) joins us to discuss a prespecified secondary analysis from the SUMMIT trial, examining sex-specific effects of tirzepatide in patients with heart failure with preserved ejection fraction and obesity.The SUMMIT…
View more
Added:
1 year ago
In the second session of Advancements in Obesity Management (AOM) 2024, the panel delve into treatment of specific CV diseases in patients living with obesity. Key co-morbidities discussed includediabetes, hypertension, dyslipidemia and thrombosis.
View more
Obesity in Focus
Added:
7 months ago
Video
Added:
9 months ago
In this short interview, we are joined by Dr Michelle Kittleson (Cedars-Sinai Heart Institute, US) to discuss the key updates and recommendations from the 2025 ACC Scientific Statement on the Management of Obesity in Adults with Heart Failure.Interview Questions:1. What is the current research landscape for heart failure patients with obesity?2. What are the new recommendations in this scientific…
View more
Added:
10 months ago
In this short interview, Dr Mohammed El-Sheikh discusses the key findings and clinical relevance of his recently published article, “Associations of Obesity and Prognostic Nutritional Index on 1-Year Mortality in Patients with Acute Heart Failure.”
View more
Added:
1 year ago
In this short interview, Dr Scott Harris (Chief Medical Officer of AltImmune Inc.) joins us to discuss the emerging role of glucagon-containing dual and triple agonists for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). Dr Harris discusses the clinical need for these drugs, as well as an outline of the current evidence for the use of incretins in the…
View more
Added:
10 months ago
In this short interview, Dr Kyaw Zaw Win discusses the importance of his recently published article, “The Management of Obesity Before Catheter Ablation of AF: The Missing Piece?”
View more